Marion Leboyer Selected Research

Arylsulfotransferase (Phenol Sulfotransferase)

1/2021

Decreased phenol sulfotransferase activities associated with hyperserotonemia in autism spectrum disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marion Leboyer Research Topics

Disease

67	Bipolar Disorder (Manic Depressive Psychosis) 07/2022 - 03/2003
45	Schizophrenia (Dementia Praecox) 11/2022 - 05/2003
20	Autism Spectrum Disorder 01/2022 - 05/2003
19	Psychotic Disorders (Schizoaffective Disorder) 07/2022 - 01/2008
17	Inflammation (Inflammations) 12/2021 - 12/2008
15	Mental Disorders (Mental Disorder) 01/2022 - 02/2005
13	Mood Disorders (Mood Disorder) 01/2022 - 12/2002
13	Autistic Disorder (Autism) 11/2020 - 03/2002
9	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 09/2014 - 01/2002
8	Infections 01/2022 - 05/2013
6	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 07/2008
6	Mania (Manias) 11/2021 - 08/2004
5	COVID-19 01/2022 - 01/2020
4	Alcoholism (Alcohol Abuse) 11/2022 - 08/2004
4	Treatment-Resistant Depressive Disorder 01/2022 - 03/2016
4	Intellectual Disability (Idiocy) 05/2014 - 06/2007
3	Genetic Risk Score 07/2022 - 01/2019
3	Substance-Related Disorders (Drug Abuse) 01/2022 - 09/2014
3	Anxiety Disorders (Anxiety Disorder) 01/2022 - 03/2003
3	Encephalitis (Encephalitis, Rasmussen) 01/2021 - 10/2016
3	Weight Gain 01/2020 - 01/2016
3	Depressive Disorder (Melancholia) 11/2017 - 10/2013
2	Craniocerebral Trauma (Head Injury) 01/2022 - 08/2004
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2019 - 01/2015
2	Neuroinflammatory Diseases 01/2018 - 03/2013
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 10/2014
2	Toxoplasmosis 01/2018 - 06/2013
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 10/2017 - 11/2011
2	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 10/2016 - 01/2015
2	Autoimmune Diseases (Autoimmune Disease) 09/2013 - 08/2013
2	Language Development Disorders (Semantic-Pragmatic Disorder) 09/2010 - 06/2007
1	Psychomotor Agitation (Akathisia) 11/2022
1	Sleep Wake Disorders 11/2022
1	Hypersensitivity (Allergy) 01/2022
1	Central Nervous System Lupus Vasculitis 02/2021
1	Atrophy 01/2021
1	Feeding and Eating Disorders (Eating Disorder) 01/2021

Drug/Important Bio-Agent (IBA)

21	Antipsychotic Agents (Antipsychotics)IBA 11/2022 - 04/2010
21	Biomarkers (Surrogate Marker)IBA 10/2021 - 12/2008
19	LithiumIBA 07/2022 - 03/2003
16	Antidepressive Agents (Antidepressants)IBA 07/2022 - 08/2004
13	Biological ProductsIBA 01/2021 - 11/2004
9	MelatoninIBA 12/2017 - 11/2002
8	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021 - 01/2015
7	C-Reactive ProteinIBA 11/2020 - 12/2008
6	Pharmaceutical PreparationsIBA 01/2021 - 09/2014
5	CytokinesIBA 07/2022 - 03/2013
5	Immunoglobulin G (IgG)IBA 02/2021 - 06/2013
5	AntibodiesIBA 01/2021 - 06/2013
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2007
4	Polytetrafluoroethylene (Teflon)FDA Link 07/2022 - 01/2019
4	CalciumIBA 01/2022 - 01/2008
4	Interleukin-6 (Interleukin 6)IBA 12/2021 - 06/2013
4	Amisulpride (Solian)IBA 01/2021 - 10/2018
4	Serotonin (5 Hydroxytryptamine)IBA 11/2020 - 02/2005
4	AutoantibodiesIBA 11/2017 - 09/2013
3	Anti-Anxiety Agents (Anxiolytics)IBA 07/2022 - 01/2021
3	Retinaldehyde (Retinal)IBA 01/2022 - 01/2022
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022 - 03/2003
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022 - 03/2002
3	CholesterolIBA 12/2021 - 10/2014
3	Oxytocin (Pitocin)FDA LinkGeneric 12/2018 - 03/2010
3	Dopamine (Intropin)FDA LinkGeneric 03/2016 - 08/2003
3	Dopamine Receptors (Dopamine Receptor)IBA 09/2014 - 03/2002
3	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 03/2010 - 01/2002
3	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 07/2008 - 12/2002
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2022 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 02/2021 - 01/2015
2	Complement System Proteins (Complement)IBA 01/2021 - 02/2013
2	env Gene ProductsIBA 01/2021 - 12/2008
2	Complement C4 (Complement Component 4)IBA 01/2021 - 11/2020
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 11/2020 - 01/2017
2	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2018
2	dectin 1IBA 01/2019 - 01/2015
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 01/2018
2	Olanzapine (Zyprexa)FDA Link 10/2018 - 08/2010
2	HLA-G Antigens (HLA G)IBA 08/2018 - 05/2013
2	AntigensIBA 01/2018 - 12/2008
2	anti-NMDA receptor autoantibodyIBA 01/2018 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2017 - 07/2015
2	Toll-Like Receptor 4IBA 01/2017 - 01/2014
2	Ketamine FDA LinkGeneric 03/2016 - 09/2014
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2014 - 05/2014
2	LigandsIBA 09/2013 - 07/2010
2	EnzymesIBA 09/2012 - 01/2011
2	Growth Hormone (Somatotropin)IBA 09/2010 - 08/2003
2	Amino Acids FDA Link 06/2007 - 01/2006
2	NeuroliginsIBA 01/2007 - 05/2003
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2022
1	Mitochondrial DNA (mtDNA)IBA 11/2021
1	Histamine Antagonists (Antihistamines)IBA 03/2021
1	Catalytic AntibodiesIBA 02/2021
1	Deoxyribonucleases (DNase)FDA Link 02/2021
1	3-hydroxykynurenineIBA 01/2021

Therapy/Procedure

9	Therapeutics 11/2021 - 03/2013
5	Precision Medicine 11/2022 - 12/2010